Hep-Lock

Name: Hep-Lock

Indications and Usage for Hep-Lock

Hep-Lock U/P (Preservative-Free Heparin Lock Flush Solution, USP) is intended to maintain patency of an indwelling venipuncture device designed for intermittent injection or infusion therapy or blood sampling. Heparin Lock Flush Solution may be used following initial placement of the device in the vein, after each injection of a medication or after withdrawal of blood for laboratory tests. (See DOSAGE AND ADMINISTRATION, Maintenance Of Patency Of Intravenous Devices for directions for use.)

Hep-Lock U/P is not to be used for anticoagulant therapy.

References

  1. Tahata T, Shigehito M, Kusuhara K, Ueda Y, et al. Delayed-Onset of Heparin Induced Thrombocytopenia – A Case Report – J Jpn Assn Torca Surg.1992;40(3):110-111.
  2. Warkentin T, Kelton J. Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis. Annals of Internal Medicine. 2001;135:502-506.
  3. Rice L, Attisha W, Drexler A, Francis J. Delayed-Onset Heparin Induced Thrombocytopenia. Annals of Internal Medicine, 2002;136:210-215.
  4. Dieck J., C. Rizo-Patron, et al. (1990). “A New Manifestation and Treatment Alternative for Heparin-Induced Thrombosis.” Chest.1990;98:1524-26.
  5. Smythe M, Stephens J, Mattson. Delayed-Onset Heparin Induced Thrombocytopenia. Annals of Emergency Medicine, 2005;45(4):417-419.
  6. Divgi A. (Reprint), Thumma S., Hari P., Friedman K., Delayed Onset Heparin-Induced Thrombocytopenia (HIT) Presenting After Undocumented Drug Exposure as Post-Angiography Pulmonary Embolism. Blood. 2003;102(11):127b.

ESI logo, Hep-Lock and Dosette are registered trademarks of Baxter International, Inc., or its subsidiaries.

Manufactured by

Baxter Healthcare Corporation

Deerfield, IL 60015 USA

For Product Inquiry 1 800 ANA DRUG (1-800-262-3784)

MLT-00090/6.0

Hep-Lock U/P 
heparin sodium injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0641-0272
Route of Administration INTRAVENOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
heparin sodium (heparin) heparin 10   in 1 mL
Inactive Ingredients
Ingredient Name Strength
sodium chloride 8 mg  in 1 mL
monobasic sodium phosphate monohydrate 2.3 mg  in 1 mL
dibasic sodium phosphate anhydrous 0.5 mg  in 1 mL
water  
Packaging
# Item Code Package Description
1 NDC:0641-0272-25 25 VIAL (25 VIAL) in 1 PACKAGE
1 1 mL (1 MILLILITER) in 1 VIAL
Hep-Lock U/P 
heparin sodium injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0641-0273
Route of Administration INTRAVENOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
heparin sodium (heparin) heparin 100   in 1 mL
Inactive Ingredients
Ingredient Name Strength
sodium chloride 8 mg  in 1 mL
monobasic sodium phosphate monohydrate 2.3 mg  in 1 mL
dibasic sodium phosphate anhydrous 0.5 mg  in 1 mL
water  
Packaging
# Item Code Package Description
1 NDC:0641-0273-25 25 VIAL (25 VIAL) in 1 PACKAGE
1 1 mL (1 MILLILITER) in 1 VIAL
Labeler - Baxter Healthcare Corporation
Revised: 01/2007   Baxter Healthcare Corporation
(web3)